Stay updated on HMPL-689 Safety & PK in Lymphomas Clinical Trial
Sign up to get notified when there's something new on the HMPL-689 Safety & PK in Lymphomas Clinical Trial page.

Latest updates to the HMPL-689 Safety & PK in Lymphomas Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoChange Detected- Revision metadata updated from v3.4.2 to v3.4.3. There are no changes to study details or user-facing features.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision: v3.4.2 implemented; no visible changes to the study details, eligibility, locations, or other user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page shows a revision update from v3.4.0 to v3.4.1 with no changes to study content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check73 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4; no substantive changes to study content or layout are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check95 days agoChange DetectedA new consolidated Locations section is added with multiple sites (California, Georgia, New York, North Carolina, Texas, Washington, and Val de Marne in France) and the revision updated to v3.3.3, replacing the prior site-specific listings.SummaryDifference0.7%

Stay in the know with updates to HMPL-689 Safety & PK in Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-689 Safety & PK in Lymphomas Clinical Trial page.